ibrutinib,venetoclax,Obinutuzumab
roche,janssen,abbvie,biogen
['cll']
excellent presentation of the gaia/cll13 study by #barbaraeichhorst at #eha2022. 
Multidisciplinary @ERANET_PerMed funded precision medicine consortium | Tailoring the targeted treatment of #CLL | Tweets by @SigridSkanland